Jeff Terrell
General Partner @ Hatteras Venture Partners
Durham, United States
Jeff Terrell is a Partner at Hatteras Venture Partners and was a Clinical Specialist and Associate Sales Rep - Medicraft at Medtronic. He attended Duke University - The Fuqua School of Business and Princeton University.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 80%
Last updated:
For AI agents: llms.txt
Industries Jeff Terrell invests in
Stages Jeff Terrell invests in
Countries Jeff Terrell invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 5 (50%)
- Medical 3 (30%)
- Medical Device 3 (30%)
- SaaS 1 (10%)
- Hospital 1 (10%)
Stage
- Series A 4 (40%)
- Series B 3 (30%)
- Series C 1 (10%)
- Funding Round 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Pharaoh Neuro
|
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients. | $20M / Series A / Feb 18, 2026 | |
Boomerang Medical
|
Boomerang Medical is a female-led bioelectronic medical technology firm that is revolutionizing the management of autoimmune illnesses. | $20M / Series B / Sep 04, 2025 | |
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $14M / Series B / Mar 17, 2025 | |
AtaCor Medical
|
AtaCor Medical Inc., is a San Clemente-based medical device maker. It designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. | $28M / Series C / Apr 24, 2024 | |
|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $7.5M / Series B / May 25, 2023 | |
Cardiosense
|
Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease. | $15.1M / Series A / Dec 08, 2022 | |
|
Boomerang Medical
|
Boomerang Medical is a female-led bioelectronic medical technology firm that is revolutionizing the management of autoimmune illnesses. | $15M / Series A / Nov 01, 2022 | |
|
AtaCor Medical
|
AtaCor Medical Inc., is a San Clemente-based medical device maker. It designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. | $25M / Series B / Apr 28, 2020 | |
|
410 Medical
|
410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $8M / Series A / Oct 22, 2019 | |
NurseGrid
|
Founded by nurses and technology entrepreneurs, NurseGrid makes integrated, intuitive staffing and communication tools just for nurses and nursing departments. NurseGrid has two products: NurseGrid Mobile & NurseGrid Manager.NurseGrid Mobile is the easiest way for nurses and healthcare workers to manage their complex schedules, connect withcolleagues, and bring more balance to their work lives. More than 300,000 nurses have downloaded NurseGrid to date and the iOS app enjoys a consistent 5 star average rating on the App Store.NurseGrid Manager allows nursing departments to simplify team communication, staffing, and schedule management, making staff and managers happier and more productive. It complements core scheduling systems such as Kronos, API, and McKesson, filling in the critical gap current technologies leave between schedule creation and timekeeping, and giving nurse leaders a cost-saving, nurse-preferred way to manage day to day staffing and scheduling needs.NurseGrid was launched in 2013. | $5.7M / Jan 18, 2018 |
Co-Investors
Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.
Hatteras Venture Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Douglas Reed
General Partner
|
|||
|
Jeff Terrell
General Partner
|
|||
Myla Lai-Goldman
Venture Partner
|
|||
Christy L. Shaffer
General Partner
|
|||
Clay B. Thorp
General Partner and Co-Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jeff Terrell invest in?
Jeff Terrell invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jeff Terrell?
Public channels for Jeff Terrell include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jeff Terrell last invest?
The most recent investment recorded for Jeff Terrell closed in Feb 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
